Cyto–reduction surgery in chemoresistant leyomyosarcoma uteri
Abstract
Cyto–reduction surgery in chemoresistant leyomyosarcoma uteri
References
1. Lehmann K, Rickenbacher A, Jang JH, Oberkofler CE, Vonlanthen R, von Boehmer L, et al. New Insight Into Hyperthermic Intraperitoneal Chemotherapy: Induction of Oxidative Stress Dramatically Enhanced Tumor Killing in In Vitro and In Vivo Models. Annals of Surgery. 2012 Nov;256(5):730-8. doi: 10.1097/ SLA. 0b013e3182737517.
2. Ray-Coquard I, Rizzo E, Blay JY, Casali P, Judson I, Hansen AK, et al. Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy. Gynecol Oncol. 2016 Jul;142(1):95-101. doi: 10.1016/ j.ygyno.2016.05.016.
2. Ray-Coquard I, Rizzo E, Blay JY, Casali P, Judson I, Hansen AK, et al. Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy. Gynecol Oncol. 2016 Jul;142(1):95-101. doi: 10.1016/ j.ygyno.2016.05.016.
Published
2019-02-28
How to Cite
Chetverikov, S. G., Atanasov, D. V., Onyshchenko, V. I., Chetverikova–Ovchynnyk, V. V., & Chetverikov, M. S. (2019). Cyto–reduction surgery in chemoresistant leyomyosarcoma uteri. Klinicheskaia Khirurgiia, 86(3), 74-76. https://doi.org/10.26779/2522-1396.2019.03.74
Section
Brief Communications
This work is licensed under a Creative Commons Attribution 4.0 International License.
